Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Male or female, above 40 years of age
2. Patients clinically diagnosed of COPD with no history suggestive of asthma:
1. by scores \>=5 in the COPD Population Screener,
2. by a clinical diagnosis of COPD made by pulmonologists or internists,
3. by a Forced Expiratory Volume (FEV1)/ Forced Vital Capacity (FVC6) ratio of \<=0.70 and a FEV1 \<=80% of the predicted value as assessed by copd-6 (Vitalograph, UK);
3. Maintenance treatment-naïve COPD patients who have been prescribed once daily long-acting bronchodilators (LABAs / LAMAs) for the first time at enrolment into the study
4. Patients who are able to provide signed informed consent
5. Patients who agree to be contacted for telephone/ SMS reminders via call center
You may not be if
1. Patients with contraindications to the prescribed medication
2. Patients with any disorder that would prevent the patient from being able to complete questionnaires either verbally or by self-completion
3. Pregnant or lactating women or women of childbearing potential not using an acceptable method of contraception
Clareo Health | Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD)
